News Headlines

  1. Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration 9/30/2025

    Avance Clinical, a global CRO headquartered in South Australia, met with Mr Jeff Robinson, South Australian Ambassador to Korea, to advance collaboration opportunities between South Australia and Korea in biotech clinical research.

  2. "Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns 9/23/2025

    Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe. The report, “Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From Europe” was published in the September 2025 issue of Value in Health.

  3. ISPOR Real-World Evidence Summit 28-30 September 2025, Tokyo, Japan 9/23/2025

    ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific.

  4. Ametris Expands Collaborative Research Project To Investigate Digital Measures Of Physical Function For Drug Development in Obesity 9/11/2025

    Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, announced the launch of Digital Endpoint Collaboration to accelerate Outcome Development (DECODE) in Obesity.

  5. Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture 9/2/2025

    Quotient Sciences announced a new partnership with the UK CPI (Centre for Process Innovation) to help accelerate mRNA therapeutics — combining CPI capabilities in LNP manufacturing and technology with Quotient Sciences' clinical and drug product development platform, Translational Pharmaceutics®.

  6. Biorasi And Ryght AI Partner To Revolutionize Clinical Trial Feasibility With Real-Time AI Insights 8/26/2025

    In a move set to redefine how biotech and biopharma sponsors plan and launch clinical trials, Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies, has partnered with Ryght AI & to bring advanced, AI-driven feasibility capabilities to biotech and biopharma sponsors.

  7. PCM Trials, EmVenio Research, And Clinical Trial Service Rebrand As EmVenio Clinical Research 8/25/2025

    EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator to improve access for trial participants.

  8. CORE 2025 - October 6-8, 2025 8/11/2025

    CORE 2025 brings together leaders across biotech, pharma, regulatory agencies, and digital health to define the future of clinical development, scale innovation into operational excellence, and foster industry-wide alignment.

  9. Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift 8/11/2025

    Crucial Data Solutions (CDS), provider of the industry’s only end-to-end eClinical platform available as a native mobile app, today announced that Leigh J. Mack, MD, PhD has rejoined the company as Chief Medical Officer. Dr. Mack, who previously served in this role from 2017 to 2021, brings renewed focus to aligning artificial intelligence (AI) with the future of regulatory compliance and clinical trial execution.

  10. ISPOR Champions Research Transparency With Launch Of Open Science Badges 8/4/2025

    ISPOR has introduced an initiative to recognize transparency in research for papers published in Value in Health, its preeminent HEOR journal.